Excalibur Group Holdings

About The Fund

Excalibur Group Holdings is a venture capital firm based in London, United Kingdom. They specialize in bridging the gap between various stages of the healthcare value chain, including research, development, production, and commercialization of drugs, medical devices, diagnostics, and related healthcare facilities. Their role extends to supply and distribution, drawing connections with individual and institutional investors, as well as equity and debt markets. The firm provides not only capital for start-up and expansion purposes but also strategic advice to guide healthcare companies towards growth milestones such as trade sales or initial public offerings (IPOs). With a focus on the biotechnology, healthcare, and life science sectors, Excalibur Group Holdings is particularly interested in biomedical areas such as oncology, where innovative therapeutic solutions are in high demand. The fund has established investment parameters, with both the minimum and maximum investment limit set at 2,940,000, reflecting a targeted and niche investment strategy where they can make impactful contributions within their domain of expertise. Key areas such as BioTech, Medical Devices, Oncology, and Hospital Services form the crux of their investment thesis, seeking to support and propel forward-looking initiatives that can cater to pressing medical challenges and contribute to the advancement of medicine and healthcare services.